Corvus Pharmaceuticals Inc (CRVS)
2.29
+0.10
(+4.57%)
USD |
NASDAQ |
May 17, 16:00
2.29
0.00 (0.00%)
Pre-Market: 20:00
Corvus Pharmaceuticals Cash from Investing (TTM): 10.93M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.93M |
| December 31, 2023 | 15.54M |
| September 30, 2023 | 13.98M |
| June 30, 2023 | -0.529M |
| March 31, 2023 | 6.90M |
| December 31, 2022 | -23.28M |
| September 30, 2022 | -21.39M |
| June 30, 2022 | -20.96M |
| March 31, 2022 | -8.86M |
| December 31, 2021 | 21.56M |
| September 30, 2021 | 24.02M |
| June 30, 2021 | 30.49M |
| March 31, 2021 | 21.92M |
| December 31, 2020 | 44.77M |
| September 30, 2020 | 48.90M |
| June 30, 2020 | 28.44M |
| March 31, 2020 | 22.18M |
| Date | Value |
|---|---|
| December 31, 2019 | 3.255M |
| September 30, 2019 | 5.194M |
| June 30, 2019 | 39.03M |
| March 31, 2019 | -25.04M |
| December 31, 2018 | -30.19M |
| September 30, 2018 | -26.05M |
| June 30, 2018 | -28.71M |
| March 31, 2018 | 70.27M |
| December 31, 2017 | 84.83M |
| September 30, 2017 | 83.03M |
| June 30, 2017 | 70.29M |
| March 31, 2017 | 34.37M |
| December 31, 2016 | -42.56M |
| September 30, 2016 | -122.26M |
| June 30, 2016 | -124.78M |
| March 31, 2016 | -150.46M |
| December 31, 2015 | -92.03M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-23.28M
Minimum
Dec 2022
48.90M
Maximum
Sep 2020
13.10M
Average
14.76M
Median
Cash from Investing (TTM) Benchmarks
| Cyclacel Pharmaceuticals Inc | -0.006M |
| Enanta Pharmaceuticals Inc | -88.40M |
| Oragenics Inc | -0.9363M |
| Nanoviricides Inc | -0.061M |
| MAIA Biotechnology Inc | -- |